CLOTRIMAZOLE VAGINAL 3 CREAM

দেশ: কানাডা

ভাষা: ইংরেজি

সূত্র: Health Canada

সক্রিয় উপাদান:

CLOTRIMAZOLE

থেকে পাওয়া:

TARO PHARMACEUTICALS INC

এটিসি কোড:

G01AF02

INN (আন্তর্জাতিক নাম):

CLOTRIMAZOLE

ডোজ:

2%

ফার্মাসিউটিকাল ফর্ম:

CREAM

রচনা:

CLOTRIMAZOLE 2%

প্রশাসন রুট:

VAGINAL

প্যাকেজ ইউনিট:

25G

প্রেসক্রিপশন টাইপ:

OTC

থেরাপিউটিক এলাকা:

AZOLES

পণ্য সারাংশ:

Active ingredient group (AIG) number: 0110231003; AHFS:

অনুমোদন অবস্থা:

APPROVED

অনুমোদন তারিখ:

2020-10-16

পণ্য বৈশিষ্ট্য

_ _
_CLOTRIMAZOLE VAGINAL 6 _
_CLOTRIMAZOLE VAGINAL 3 _
_CLOTRIMAZOLE EXTERNAL CREAM _
_CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM _
_CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM _
_ PAGE 1 OF 29 _
PRODUCT MONOGRAPH
CLOTRIMAZOLE VAGINAL 6
(Clotrimazole Vaginal Cream USP 1%)
CLOTRIMAZOLE VAGINAL 3
(Clotrimazole Vaginal Cream USP 2%)
CLOTRIMAZOLE EXTERNAL CREAM
(Clotrimazole
Cream USP 1%) CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM
(Clotrimazole
Cream USP 1%)
CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL
CREAM
(Clotrimazole
Cream USP 2%)
ANTIFUNGAL AGENT
Taro Pharmaceuticals
Inc.
Date of Revision:
130 East Drive
April 29, 2022
Brampton, Ontario
L6T 1C1
Control # 263251
_ _
_CLOTRIMAZOLE VAGINAL 6 _
_CLOTRIMAZOLE VAGINAL 3 _
_CLOTRIMAZOLE EXTERNAL CREAM _
_CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM _
_CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM _
_ PAGE 2 OF 29 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................................
3
SUMMARY
PRODUCT
INFORMATION
............................................................................................
3
INDICATIONS
AND
CLINICAL
USE..................................................................................................
3
CONTRAINDICATIONS
.....................................................................................................................
4
WARNINGS
AND
PRECAUTIONS
.....................................................................................................
4
ADVERSE
REACTIONS
.....................................................................................................................
5
DRUG
INTERACTIONS
......................................................................................................................
6
DOSAGE
AND
ADMINISTRATION
...................................................................................................
6
OVERDOSAGE
...................................................................................................